Role of the bed nucleus of the stria terminalis in the acquisition and expression of conditioned defeat in Syrian hamsters.
When Syrian hamsters (Mesocricetus auratus) are defeated by a larger, more aggressive opponent, they subsequently produce more defensive and submissive behaviors and less chemosensory investigation and aggression, even when they are paired with a smaller, non-aggressive intruder. This persistent change in the behavior of defeated animals has been termed conditioned defeat. In the present study, we tested the hypothesis that the bed nucleus of the stria terminalis (BNST) is important for the acquisition and expression of conditioned defeat. We found that the GABA(A) receptor agonist muscimol infused into the BNST immediately prior to initial defeat training failed to disrupt the acquisition of conditioned defeat, while muscimol infused prior to testing caused a significant reduction in submissive/defensive behaviors and an increase in investigatory behaviors of the non-aggressive intruder. These results indicate that (1) the BNST, unlike the amygdala, does not appear to be critically involved in the consolidation process related to the memory of social defeat and (2) the BNST may be an important site for the execution of fear behaviors associated with social defeat. Considering the high degree of connectivity between the BNST and the amygdala, these findings provide further insight into the neural circuitry governing conditioned defeat and support the view of a functional dissociation between the amygdala and the BNST in the modulation of conditioned fear in an ethologically relevant model.
Markham
Chris M
CM
Department of Psychology and the Center for Behavioral Neuroscience, Georgia State University, Atlanta, GA 30303, USA. psycmm@langate.gsu.edu
Norvelle
Alisa
A
Huhman
Kim L
KL
D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D000818:Animals; D003214:Conditioning, Classical / Q000187:drug effects* / Q000502:physiology; D006224:Cricetinae; D005239:Fear / Q000187:drug effects* / Q000523:psychology; D018755:GABA Agonists / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008647:Mesocricetus; D008845:Microinjections / Q000379:methods; D009118:Muscimol / Q000008:administration & dosage / Q000494:pharmacology*; D011930:Reaction Time / Q000187:drug effects; D012686:Septal Nuclei / Q000187:drug effects*; D012919:Social Behavior; D013238:Stereotaxic Techniques; D013997:Time Factors
D018755:GABA Agonists; D009118:Muscimol